World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
56
Citations
20181
World Ranking
14161
National Ranking
32

George L. Daikos publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where George L. Daikos sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 188 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

George L. Daikos D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where George L. Daikos sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 56 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 1999 - European Society for Clinical Microbiology and Infectious Diseases Excellence Award

Overview

George L. Daikos is affiliated with the National and Kapodistrian University of Athens in Greece. Their research spans multiple areas within medicine and biochemistry, genetics, and molecular biology, focusing extensively on infectious diseases and antimicrobial resistance.

The scientist has published widely in several frequent venues, including:

  • Clinical Microbiology and Infection
  • Infectious Diseases and Therapy
  • Antibiotics
  • Journal of Antimicrobial Chemotherapy
  • Clinical Infectious Diseases

Their work covers main fields of study such as Medicine and Biochemistry, Genetics, and Molecular Biology with notable subfields in Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Epidemiology, and Clinical Biochemistry.

The principal topics addressed in their publications include:

  • Antibiotic Resistance in Bacteria
  • Antibiotic Use and Resistance
  • Antibiotics Pharmacokinetics and Efficacy
  • Pneumonia and Respiratory Infections
  • Bacterial Identification and Susceptibility Testing
  • Vibrio bacteria research studies
  • Urinary Tract Infections Management

George L. Daikos has coauthored numerous papers with frequent collaborators such as Mical Paul, Yehuda Carmeli, Emanuele Durante-Mangoni, Leonard Leibovici, and Amir Nutman.

Recent publications include:

  • European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli, 2021, Clinical Microbiology and Infection
  • Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing Enterobacterales, 2020, Clinical Infectious Diseases
  • Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms, 2022, NEJM Evidence
  • Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study, 2020, Journal of Antimicrobial Chemotherapy
  • Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by Pseudomonas aeruginosa, 2021, Antibiotics

In 1999, George L. Daikos received the European Society for Clinical Microbiology and Infectious Diseases Excellence Award.

Best Publications

  • Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

    L Silvia Munoz-Price;L Silvia Munoz-Price;Laurent Poirel;Robert A Bonomo;Robert A Bonomo;Mitchell J Schwaber

  • Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions

    L. S. Tzouvelekis;A. Markogiannakis;M. Psichogiou;P. T. Tassios

  • International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).

    Brian T. Tsuji;Jason M. Pogue;Alexandre P. Zavascki;Mical Paul;Mical Paul

  • Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems

    George L. Daikos;Sophia Tsaousi;Leonidas S. Tzouvelekis;Ioannis Anyfantis

  • Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

    Mical Paul;Mical Paul;George L Daikos;Emanuele Durante-Mangoni;Dafna Yahav;Dafna Yahav

  • Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

    Belén Gutiérrez-Gutiérrez;Elena Salamanca;Marina de Cueto;Po-Ren Hsueh

  • An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection.

    Margaret A. Fischl;Raj B. Uttamchandani;George L. Daikos;Rita B. Poblete

  • Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial

    Richard G. Wunderink;Evangelos J. Giamarellos-Bourboulis;Galia Rahav;Amy J. Mathers

  • Treating infections caused by carbapenemase-producing Enterobacteriaceae

    L.S. Tzouvelekis;A. Markogiannakis;E. Piperaki;M. Souli

  • Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control

    Y. Carmeli;M. Akova;G. Cornaglia;G. L. Daikos

  • Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase–Producing Enterobacterales

    Marco Falcone;George L Daikos;Giusy Tiseo;Dimitrios Bassoulis

  • CLINICAL PRESENTATION AND OUTCOME OF PATIENTS WITH HIV INFECTION AND TUBERCULOSIS CAUSED BY MULTIPLE-DRUG– RESISTANT BACILLI

    Margaret A. Fischl;George L. Daikos;Raj B. Uttamchandani;Rita B. Poblete

  • Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

    G.L. Daikos;A. Markogiannakis

  • Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control

    A P Magiorakos;K Burns;J Rodríguez Baño;M Borg

  • Prospective Observational Study of the Impact of VIM-1 Metallo-β-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections

    George L. Daikos;Panayiotis Petrikkos;Mina Psichogiou;Chris Kosmidis

  • Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria

    M. Akova;G.L. Daikos;L. Tzouvelekis;Y. Carmeli

  • Nocardiosis in 30 Patients with Advanced Human Immunodeficiency Virus Infection: Clinical Features and Outcome

    Raj B. Uttamchandani;George L. Daikos;Ricardo R. Reyes;Margaret A. Fischl

  • Adaptive Resistance to Aminoglycoside Antibiotics from First-Exposure Down-Regulation

    George L. Daikos;George Gee Jackson;Valentina T. Lolans;David M. Livermore

  • Does rituximab increase the incidence of infectious complications? A narrative review

    Theodoros Kelesidis;George Daikos;Dimitrios Boumpas;Sotirios Tsiodras

  • Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis

    Alessandro Cassini;Liselotte Diaz Hogberg;Diamantis Plachouras;Annalisa Quattrocchi

Frequent Co-Authors

Yehuda Carmeli
Yehuda Carmeli Tel Aviv University
Leonard Leibovici
Leonard Leibovici Tel Aviv University
Leonidas S. Tzouvelekis
Leonidas S. Tzouvelekis National and Kapodistrian University of Athens
Johan W. Mouton
Johan W. Mouton Radboud University Medical Center
Stéphan Juergen Harbarth
Stéphan Juergen Harbarth University of Geneva
Robert A. Bonomo
Robert A. Bonomo Case Western Reserve University
George Gee Jackson
George Gee Jackson University of Illinois at Chicago
David L. Paterson
David L. Paterson University of Queensland
Jesús Rodríguez-Baño
Jesús Rodríguez-Baño University of Seville
Helen Giamarellou
Helen Giamarellou National and Kapodistrian University of Athens

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology or Biochemistry can open doors to a vast array of online graduate degrees and dynamic career pathways in healthcare and research. Professionals may want to consider the number of cahme accredited mha programs available for those seeking leadership roles in hospital and healthcare administration, ensuring quality standards are met.

For those interested in advanced nursing positions but preferring a flexible path, online dnp programs without clinicals provide doctoral-level training without the need for on-site clinical hours. Additionally, a doctorate in healthcare management equips graduates with strategic and operational expertise to lead healthcare organizations or pursue roles in policy, consulting, or higher education.

If pharmacy is your focus, reviewing the best online pharmacy school options can help you advance from laboratory sciences into pharmaceutical care, drug development, or research. Each of these online degree paths leverages your biology and biochemistry background while offering specialized, in-demand career trajectories.

Best Scientists Citing George L. Daikos

Trending Scientists

Recently Published Articles